Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

) Intrahepatic cholangiocarcinoma (closed to accrual 03/20/2018) Extrahepatic cholangiocarcinoma and bile duct tumors (closed to accrual 03/20/2018) Sarcomatoid carcinoma of

thyroidectomy
systemic therapy
squamous cell carcinoma of the head and neck
intrahepatic bile duct carcinoma
thyroiditis
  • 6634 views
  • 10 Aug, 2022
  • 752 locations
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma

-positive extrahepatic cholangiocarcinoma.

renal function
capecitabine
adjuvant chemotherapy
metastasis
carcinoma
  • 15 views
  • 24 Feb, 2022
  • 1 location
An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

extrahepatic cholangiocarcinoma.

oxaliplatin
Accepts healthy volunteers
neutrophil count
TACE
measurable disease
  • 0 views
  • 25 Jul, 2022
  • 1 location
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Target population: patients with advanced biliary tract cancer (including gallbladder carcinoma, intrahepatic and extrahepatic cholangiocarcinoma) . Primary objective

  • 0 views
  • 22 Jan, 2021
  • 1 location
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

The purpose of this study is to prospectively determine the effects of administering proton pump inhibitors (PPIs) following pancreaticoduodenectomy on postoperative outcomes. The findings of this study will help in avoiding the widespread use of PPIs during the immediate postoperative period following pancreatic surgery.

pancreaticoduodenectomy
disease or disorder
  • 0 views
  • 15 May, 2022
  • 1 location
A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

A Phase Ⅱ, open-label, single-arm study to assess the safety, tolerability, and efficacy of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer.

  • 0 views
  • 06 Jan, 2022
  • 1 location
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

This study is a Phase 1b/2 multi-center study to assess the safety, tolerability, pharmacokinetics of CTX-009 (ABL001) in combination with Irinotecan or Paclitaxel in patients with advanced or metastatic solid tumors.

  • 0 views
  • 12 Jul, 2022
  • 4 locations
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC (GAIN)

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)

cisplatin/gemcitabine
renal function
international normalized ratio
psychiatric disorder
adjuvant chemotherapy
  • 4 views
  • 18 Feb, 2022
  • 1 location
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

This is an open-label, prospective phase two basket trial assessing the efficacy of ulixertinib in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies. All patients enrolled must have a mitogen-activated protein kinase (MAPK) activating mutation to be deemed eligible for trial participation. Each disease-based basket will open to enrollment …

cancer
absolute neutrophil count
adenocarcinoma
nab-paclitaxel
BRAF
  • 0 views
  • 21 Jul, 2022
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (PLATON)

PLATON (Platform for Analyzing Targetable Mutations) is a prospective, multicentre, observational cohort study with biobanking. In a first approach PLATON's pilot-study assesses genomic profiling in gastrointestinal cancer therapy and the frequencies of targetable mutations including Tumor Mutational Burden (TMB) and Microsatellite Instability Status (MSI), performing Next-generation deep sequencing (NGS) using …

breast ductal carcinoma
cancer
pancreatic ductal adenocarcinoma
gastrointestinal cancer
adenocarcinoma
  • 0 views
  • 14 Jun, 2022
  • 30 locations